The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
AACR Annual Meeting 2022 is scheduled for April 8-13, 2022, in New Orleans, LA. More details here: https://myaacr.aacr.org/LiveEventsList.
AACR 2022 News
How has the COVID-19 pandemic affected pediatric care?
May 4, 2022 -- What impact has the COVID-19 pandemic had on the care of pediatric cancer patients internationally? It depends on the country, according to Dr. Muhammed Elhadi of the University of Tripoli in Libya. Elhadi spoke with ScienceBoard.net at the recent American Association for Cancer Research meeting in New Orleans. Read More
New pathology task force promoted at AACR
May 2, 2022 -- A pathology task force has been formed with the goal of promoting pathology's role in cancer research, according to Anil Parwani, PhD, professor of pathology at The Ohio State University. Parwani shed light on the new task force in an interview with ScienceBoard.net at the recent American Association for Cancer Research (AACR) meeting in New Orleans. Read More
CoVac-1 vaccine shows promise for immunocompromised patients
May 2, 2022 -- At the recent American Association for Cancer Research meeting in New Orleans, ScienceBoard.net spoke with the University of Tübingen’s Dr. Juliane Walz, professor of peptide-based immunotherapies, and research associate Claudia Tandler about the promising results their CoVac-1 vaccine has shown in immunocompromised patients. Read More
Context Therapeutics highlights data on ONA-XR and CLDN6 at AACR 2022
April 22, 2022 -- Context Therapeutics released preclinical data from two of its clinical programs to treat women’s cancers at the American Association for Cancer Research (AACR) annual meeting. ScienceBoard spoke with Context Therapeutics CEO and co-founder Martin Lehr at the show. Read More
AACR 2022 video: Project GENIE spurs sharing of real-world data
April 12, 2022 -- At this week's American Association for Cancer Research (AACR) 2022 annual meeting, ScienceBoard.net spoke with Shawn Sweeney, PhD, the director of the AACR Project GENIE Coordinating Center and project lead. Read More
NiKang Therapeutics presents preclinical data at AACR
April 12, 2022 -- NiKang Therapeutics presented preclinical data for NKT2152, a small molecule that inhibits hypoxia-inducible factor 2α (HIF2α), at the American Association for Cancer Research (AACR) Annual Meeting 2022. Read More
AACR 2022 video: AACR taskforce tackles public trust in science
April 11, 2022 -- NEW ORLEANS -- On day four of the American Association for Cancer Research (AACR) meeting, ScienceBoard.net spoke with Dr. Jesse Nodora, PhD, of the Moores Cancer Center at the University of California San Diego Health, a member of the new AACR taskforce devoted to the concept of trust in science. Read More
Nivolumab/chemo combo will change lung cancer care
April 11, 2022 -- A new study that pairs neoadjuvant nivolumab with chemotherapy for patients with nonsmall cell lung cancer has the potential to revolutionize treatment, according to one expert. The research was presented April 11 at the American Association for Cancer Research 2022 meeting and published simultaneously in the New England Journal of Medicine. Read More
AACR 2022: Video preview of day 3
April 10, 2022 -- NEW ORLEANS - ScienceBoard.net Editor Leah Sherwood gives a preview of the events on day three of the American Association for Cancer Research (AACR) 2022 Annual Meeting. Read More
CAR T-cells show preliminary efficacy, safety as solid-tumor treatment
April 10, 2022 -- Researchers presented phase I/II preliminary clinical trial data demonstrating the safety and efficacy of a new CAR T-cell therapy that can be used as either a monotherapy or a combination therapy to treat Claudin 6-positive solid tumors. The findings were presented at the American Association for Cancer Research Annual Meeting 2022 in New Orleans. Read More
AACR 2022 Industry News
NKILT moves from stealth mode to active fundraising
April 19, 2022 -- ScienceBoard.net recently caught up with NKILT Therapeutics leaders Raphael Ognar and Henri Bayle at the 2022 American Association for Cancer Research Annual Meeting in New Orleans. Read More
Gennao Bio presents results for gene monoclonal antibody platform at AACR 2022
April 19, 2022 -- Gennao Bio is highlighting results presented at the American Association for Cancer Research (AACR) 2022 Annual Meeting on its nonviral gene monoclonal antibody platform in multiple solid tumor models. Read More
AACR 2022 video: DCIS lesions may affect treatment management
April 13, 2022 -- NEW ORLEANS -- In an interview with ScienceBoard.net, Tanjina Kader, PhD, of the Women's Cancer Research Program at the Sir Peter MacCallum Cancer Centre in Australia, shares an overview of her research on ductal carcinoma in situ (DCIS) at the American Association for Cancer Research (AACR) Annual Meeting. Read More
Agilent demonstrates cell analysis solutions for cancer at AACR 2022
April 12, 2022 -- Agilent Technologies will display its cancer research tools for the enhanced study of cell functionality, characteristics, and other properties at the American Association for Cancer Research (AACR) 2022 Annual Meeting held in New Orleans. Read More
PerkinElmer expands in vivo imaging portfolio
April 11, 2022 -- PerkinElmer announced it is expanding its in vivo imaging portfolio with the launch of the Vega imaging system. The company said it will demonstrate Vega at the American Association of Cancer Research Annual Meeting held April 8-13 in New Orleans. Read More
Oxford BioTherapeutics to present clinical data at AACR
April 11, 2022 -- Oxford BioTherapeutics will present preliminary clinical data from its ongoing expansion phase I trial of its experimental CD205-directed antibody drug conjugate, OBT076, on April 11 at the American Association of Cancer Research (AACR) Annual Meeting. Read More
BostonGene to present 6 posters at AACR
April 11, 2022 -- BostonGene will present six poster presentations at the American Association for Cancer Research (AACR) Annual Meeting held April 8-13 in New Orleans. The presentations will highlight BostonGene’s advancement of novel analytical tools and technologies developed to enhance detection and diagnosis in cancer patients. Read More
Tvardi’s TTI-101 overcomes palbociclib resistance in breast cancer models
April 11, 2022 -- Tvardi Therapeutics will present preclinical data on April 11 at the 2022 Annual Meeting of the American Association for Cancer Research in New Orleans. Read More
Clovis Oncology highlights data on cancer therapies at AACR 2022
April 11, 2022 -- Clovis Oncology is highlighting nonclinical study data for its potential cancer therapies fibroblast activation protein-2286 and Rubraca at the American Association of Cancer Research’s 2022 (AACR) Annual Meeting held in New Orleans. Additionally, the company will present information about phase I of its upcoming Lumiere study. Read More
Vizgen to showcase Merscope results at AACR 2022
April 8, 2022 -- Life sciences company Vizgen announced that it will showcase data for understanding the tumor microenvironment from its spatial genomics platform Merscope at the American Association for Cancer Research (AACR) Annual Meeting, held April 8-13. Read More